Marinus secures European Commission approval for Ztalmy, triggering milestone payment


Approval of the anti-seizure drug triggered a milestone payment for Marinus Pharmaceuticals under its collaboration agreement with Orion Corp.

Previous Stream scores win in Austin allowing Dirty Sixth transformation planning to proceed
Next Denver office leasing on the rise but in hot spots; same with industrial space